NCT07209722

Brief Summary

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,377

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
4 months until next milestone

Results Posted

Study results publicly available

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

September 29, 2025

Results QC Date

December 3, 2025

Last Update Submit

January 22, 2026

Conditions

PrEP Precriptions for Reproductive Aged Women

Outcome Measures

Primary Outcomes (1)

  • PrEP Prescriptions

    Number of participants receiving a new PrEP prescription during the recruitment period

    8 months

Study Arms (2)

Sexual Health-PRO

Patients seen during routine GYN clinic visit.

Behavioral: PrEP acronym (pre-exposure prophylaxis)

Post visit (fidelity) survey

Patients who completed the survey outside of clinic visit

Behavioral: PrEP acronym (pre-exposure prophylaxis)

Interventions

PrEP acronym (pre-exposure prophylaxis)BEHAVIORAL

Tracked PrEP prescriptions over 8 months among patients who completed the survey

Post visit (fidelity) surveySexual Health-PRO

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Reproductive aged women, 18-45, who attended their regular GYN clinic visit

You may qualify if:

  • Patient of UAB GYN clinic

You may not qualify if:

  • Not a patient of UAB GYN clinic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35222, United States

Location

MeSH Terms

Interventions

Pre-Exposure Prophylaxis

Intervention Hierarchy (Ancestors)

Primary PreventionPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPublic Health PracticePublic HealthEnvironment and Public Health

Results Point of Contact

Title
Bernadette Johnson
Organization
UAB
bajohnson@uabmc.edu
205-934-7329

Study Officials

  • Michael Mugavero, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 29, 2025

First Posted

October 7, 2025

Study Start

September 22, 2023

Primary Completion

August 16, 2025

Study Completion

August 16, 2025

Last Updated

January 26, 2026

Results First Posted

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)